Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex.
about
Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecinEndothelial cell activation and neovascularization are prominent in dermatomyositisUnderstanding the biosynthesis of platelets-derived extracellular vesiclesOn the origin of microparticles: From "platelet dust" to mediators of intercellular communicationMicrovesicle shedding and lysosomal repair fulfill divergent cellular needs during the repair of streptolysin O-induced plasmalemmal damageTime course of complement activation and inhibitor expression after ischemic injury of rat myocardiumCell damage at the origin of antiphospholipid antibodies and their pathogenic potential in recurrent pregnancy lossEculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS.Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab.The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases.Evaluation of adenovirus-delivered human CD59 as a potential therapy for AMD in a model of human membrane attack complex formation on murine RPE.The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cellsCirculating microparticles in patients with antiphospholipid antibodies: characterization and associations.Microparticles in stored red blood cells as potential mediators of transfusion complicationsInterferon-beta1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosisEndothelial cell microparticles act as centers of matrix metalloproteinsase-2 (MMP-2) activation and vascular matrix remodeling.Role of complement and complement regulatory proteins in the complications of diabetesBlockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.Interactions between coagulation and complement--their role in inflammationCirculating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer.Complement Activation in Arterial and Venous Thrombosis is Mediated by PlasminA phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.A novel pathway of cellular activation mediated by antiphospholipid antibody-induced extracellular vesiclesCharacterizing blood microparticles: technical aspects and challenges.Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.Microparticles: new light shed on the understanding of venous thromboembolism.Regulation of human platelet aggregation by genetically modified pig endothelial cells and thrombin inhibition.Colocalization of neutrophils, extracellular DNA and coagulation factors during NETosis: Development and utility of an immunofluorescence-based microscopy platform.Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern.In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.Disseminated intravascular coagulation: diagnosis and treatment.Phosphatidylserine-mediated adhesion of T-cells to endothelial cells.Mechanism of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipientsActivation of prothrombin in the presence of human umbilical-vein endothelial cells.Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants.Use of annexin-V to demonstrate the role of phosphatidylserine exposure in the maintenance of haemostatic balance by endothelial cells.Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial-cell-mediated thrombin formation.Innate immunity and coagulation.Comparison between Ca2+-induced scrambling of various fluorescently labelled lipid analogues in red blood cells.Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation.
P2860
Q24795283-EC0CCB24-23D4-4B4C-BA3F-824FEE8C98E1Q25256876-89FCAB59-62AA-4029-832C-0A74420938CAQ26784612-EBAF1B4E-51D8-41BB-A4A4-53A63367CA80Q27023547-D9EAE84C-BAA7-4A85-9354-A20B1F58D19DQ27320039-4B8CF872-353A-4E60-A288-31EB315644BEQ28568260-62AD3D50-583C-4914-8C59-370EB2B8C922Q33379576-8C0BD912-F57D-4E52-B656-E293414ED646Q33421669-18185565-AEE4-4079-A4E7-2E74B675CAC8Q33800427-ECCB7537-C717-4AE8-B82F-FD7483411923Q33916623-5F9FC95A-90E0-4F57-A543-BF1F58FC7F48Q34069606-D5A449B7-7DE7-4CCC-A39E-ECC766DB65C0Q34213160-5A8C3F1E-225E-4DCC-BD1C-A4743A25623EQ34749444-40A389CF-36E8-4F65-BBFB-2D86FD784F70Q34983553-9FA8BA0B-45DE-4087-84BB-5AD53DF9A7C0Q35060112-4E09F930-E0A8-4A13-8D1E-DA242B795D85Q35489022-66815BF8-61F4-43B1-AA3F-DF25FACDB0A1Q35657115-C77D01F5-EF52-43AB-8BE8-A6D65B2D8567Q35763398-7E27EF9A-9F59-4A37-B626-22DECBE5E977Q36022738-2A2E8A4B-3B9A-445F-9079-E5BD54AAA9F8Q36447619-FB49D72B-D46E-4F99-BABA-D65D5A3A3C30Q36754151-891F3CFA-05E7-496C-90C3-D9243B272B05Q36915890-D69BF7B3-C543-4347-90E3-C105E0D9071EQ36928587-425DE4A3-CDD9-4314-83AA-CB29FF37EB90Q37004064-25A256D0-3BBC-478E-87DB-599EF790DCD8Q37453921-B987C0BF-47C2-4C41-87EA-7B5F41524FD5Q38242740-BBA35F53-EDAC-4AB1-96B5-CE7B3FAFDDD4Q39246204-879A2BC5-3737-4A65-B54F-6EED8823B45AQ39693062-F5C6CCBB-97D1-440A-8882-A201FA7C0E65Q40269037-4F0E145F-FF28-4BFB-8901-2C86FB3C2CB9Q40851071-576EDABB-3343-4BC1-9484-062D00735CABQ40968013-F77534E5-5726-4D6B-B9E8-C59133EBBAC2Q41820178-C0030E55-7C57-4107-8B25-79D8B34404EEQ41871449-28DF6326-9427-4778-997C-9375046E88F5Q42036516-96DFAD42-A887-4A93-B913-759939321ACEQ42361529-0FA82C41-5ACF-4FBA-888C-4A60B42EFCFAQ42450745-6E0B549B-51BC-4AC2-8198-59C553000E46Q42828832-B20B952C-1110-423C-B4E2-0528853BBAD2Q42856952-A0529FD9-A03D-4416-B458-6AB9D5F0A30FQ43001265-A4A1FAD1-0227-49B7-B882-E60E28785458Q50042914-A1C88CA0-9347-464F-BFCA-B115D22583D8
P2860
Complement proteins C5b-9 induce vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Complement proteins C5b-9 indu ...... prothrombinase enzyme complex.
@en
Complement proteins C5b-9 indu ...... prothrombinase enzyme complex.
@nl
type
label
Complement proteins C5b-9 indu ...... prothrombinase enzyme complex.
@en
Complement proteins C5b-9 indu ...... prothrombinase enzyme complex.
@nl
prefLabel
Complement proteins C5b-9 indu ...... prothrombinase enzyme complex.
@en
Complement proteins C5b-9 indu ...... prothrombinase enzyme complex.
@nl
P2093
P1476
Complement proteins C5b-9 indu ...... prothrombinase enzyme complex.
@en
P2093
P304
P407
P577
1990-03-01T00:00:00Z